Beta Bionics, Inc. (BBNX) Gross Margin
- Gross margin · 12 months: Value 58.31%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 58.31% | Gross profit / revenue. Period ending 2026-06-30. $69.40M ÷ $119.01M × 100 ≈ 58.31% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 69.40M USD | Gross Profit |
| Revenue | 119.01M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 49.61M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $69.40M | $119.01M | $49.61M | 58.31% |
| 2026-03-31 | $63.00M | $110.24M | $47.23M | 57.15% |
| 2025-12-31 | $55.54M | $100.25M | $44.71M | 55.40% |
| 2025-09-30 | $48.28M | $88.57M | $40.29M | 54.51% |
| 2025-06-30 | $42.08M | $78.02M | $35.95M | 53.93% |
| 2025-03-31 | $37.66M | $69.83M | $32.17M | 53.93% |
| 2024-12-31 | $35.89M | $65.12M | $29.24M | 55.11% |
| 2024-09-30 | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) |
| 2023-12-31 | $6.31M | $11.99M | $5.69M | 52.59% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |